Benzodiazepine Drugs Market Set to Record US$ 2.6 Bn by 2026; the U.S. to Remain Attractive Market

The U.S. is expected to account for around one-third of the total share in the global benzodiazepine drugs market by 2026. Growing prevalence of anxiety in parallel with rising awareness regarding benzodiazepine drugs.

ACG Inspection Introduces Groundbreaking Blockchain based Brand Platform

ACG Inspection one of the four businesses of ACG Group, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical industry has introduced an advanced blockchain based solution.

NeuroSense initiates clinical studies to evaluate benefit of PrimeC for ALS patients

NeuroSense Therapeutics announced the initiation of two clinical studies to evaluate the benefit of PrimeC for ALS patients.

Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus

Regeneron announced an expanded agreement with the U.S. Department of Health and Human Services (HHS) to develop new treatments combating...

Vetter pharma aligns its development service laboratory portfolio

Vetter has brought together its development laboratories in one Ravensburg site end of last year. Designed to improve workflow and enhance customer benefits within the daily support...

CPhI Southeast Asia Report: executives call for track-and-trace schemes in Southeast Asia

CPhI's ASEAN Pharma 2020 Report points points to Thailand and Indonesia having the largest near-term generics export potential, as regional executives...

Thermo Fisher Introduces NGS Based Solution for Expanded Carrier Screening Research

Thermo Fisher Scientific introduced a new next-generation sequencing based solution that enables reproductive health researchers to more efficiently...